Eligibility is described as a BMI of 30 or above, or 27 or above with at least one weight-related condition such as hypertension, type 2 diabetes, cardiovascular disease or sleep apnea
"FDA Approves New Treatment for Diabetes" (Press release)
The current pipeline of investigational, muscle-preserving therapies comprises 32 assets, of which 47% are at preclinical stage, 22% in phase 1 and 31% in phase 2, as the most advanced candidates
Visual Check: The solution should be a clear, pink-to-red liquid
Clinical practice recommendations for management of diabetes mellitus in Arab region: an expert consensus statement from Arab diabetes forum (ADF)
Results of RNA-Seq showed that the expression of cold-inducible RNA-binding protein (Cirbp) decreased in the elderly donor heart due to low temperature, leading to severe ferroptosis in recipient hearts after transplantation